Given Birth After FSS | Not Given Birth After FSS | P-value | |
---|---|---|---|
N (%) | 9 (25) | 27 (75) | |
Mean age, years (range) | 28 (23–37) | 29 (19–39) | 0.626 |
Previous parity, n (%) | |||
0 | 5 (56) | 22 (81) | 0.133 |
1 | 3 (33) | 3 (11) | |
2 | 1 (11) | 1 (4) | |
≥ 3 | 0 | 0 | |
FIGO stage, n (%) | |||
IA | 5 (56) | 22 (81) | 0.184 |
IB | – | – | |
IC | 4 (44) | 5 (19) | |
IC1 | 4 | 2 | |
IC2 | 3 | ||
IC3 | – | – | |
Histologic type, n (%) | |||
Serous, high-grade | 2 (7) | ||
Serous, low-grade | 1 (11) | ||
Mucinous | 4 (44) | 14 (52) | |
Endometrioid | 4 (44) | 6 (22) | |
Grade 1 | 3 | 3 | |
Grade 2 | 2 | ||
Grade 3 | 1 | – | |
Clear cell | 0 | 3 | |
Other a | 0 | 2 | |
Surgical mode,b n (%) | |||
Open | 6 (67) | 21 (78) | 0.335 |
Laparoscopy | 3 (33) | 3 (11) | |
Robot | 0 | 3 (11) | |
Type of surgery, n (%) | |||
Primary | 4 (44) | 13 (48) | |
Re-staging | 5 (56) | 14 (52) | |
Type of staging procedure, n (%) | |||
Cytology | 8 (89) | 22 (82) | |
Peritoneal biopsies | 9 (100) | 27 (100) | |
Oment | 6 (67) | 20 (74) | |
LN pelvic | 1 (11) | 2 (7) | |
LN paraaortic | 1 (11) | 3 (11) | |
Adjuvant chemotherapy, n (%) | 4 (44) | 9 (33) | 0.693 |
Histologic review,c n (%) | 8 (89) | 25 (93) | 1.00 |
Recurrence, n (%) | 0 | 2 (7) | |
Died of disease, n (%) | 0 | 1 (4) | |
Follow-up, months, mean (range) | 75 (44–111) | 56 (16–99) | 0.04 |